Tg therapeutics inc

Major-Pharmaceuticals

TGTX


2 Gansevoort Street
New York , NY 10014

Executive/
Director

Price

  • Last Close
  • $ 30.03
    $ -1.03 -3.3 %
    Jan 3, 2025
  • 52-Week High/Low
  • $25.19 - $6.68
  • YTD
  • -0.2%

  • Trading Volume
  • 81,656
  • Market Cap Full
  • $ 4.5B
  • Shares Outstanding
  • 151.4M
    Nov 1, 2023
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Q1 -28.6% 150.5% 73.2% 96.1% -5% -7.2% -50% 27.1% -11.4% -0.2%
Q2 -28.9% -13.7% -4.4% -0.3% 4% -19.6% -55.3% 65.2% 21.2% -
Q3 27.7% 17.9% -58.4% -34.9% 8% -12.3% 39.3% -66.3% 18.9% -
Q4 -39.9% -31.7% -25.6% 101.3% 94.4% -44.2% 99.8% 109.3% -2.2% -
J F M A M J J A S O N D
2025 -0.2% - - - - - - - - - - -
2024 -4.9% 6% -12.1% -6.2% 14.8% 9.8% 10.5% 18.9% - - - -13.5%
    2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
    -25%-61%76%-50%173%364%-63%-38%44%76%-0%

Earnings

2016 2017 2018 2019 2020 2021 2022 2023
Q1 0.19 0.52 -0.59 -0.43 -0.48 -0.69 -0.51 -0.28
Q2 0.33 0.45 -0.59 -0.42 -0.47 -0.59 -0.3 -0.34
Q3 0.50 0.48 -0.43 -0.69 -0.73 -0.65 -0.26 0.73
Q4 0.48 0.46 -0.69 -0.42 -0.74 -0.7 -0.39 -
A 1.5 1.9 -2.3 -2 -2.4 -2.6 -1.5 0.11

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2018 2019 2020 2021 2022 2023
Mar - 83.9 109.4 140.6 142.8 146.4
Jun 78 90.8 113.7 141.5 144.4 149.4
Sep 82.8 94.8 126.6 142.8 145.3 151
Dec 82.9 99.6 131.5 142.9 145.3 151.4

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover 0.2 0.2 - - -
Total Asset Turnover - - - - -
Leverage
Debt Ratio 0.4 0.2 - 0.2 -
Debt – Equity Ratio 1.2 0.3 - 0.7 -
Interest Coverage -38.6 -115 -54.8 -42.3 174
Equity multiplier 0.3 0.2 - 0.1 0.2